ABVC BioPharma Ownership 2024 | Who Owns ABVC BioPharma Now?


OverviewRevenueFinancialsChart

Institutional Ownership

1.78%

Insider Ownership

26.25%

Retail Ownership

71.97%

Institutional Holders

8.00

ABVC BioPharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----129-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----18,421-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----22,101-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----139,282-100.00%-Sep 30, 2023
BLACKROCK INC.----5,814-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.----1,000-100.00%-Sep 30, 2023

ABVC BioPharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----129-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----18,421-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----22,101-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----139,282-100.00%-Sep 30, 2023
BLACKROCK INC.----5,814-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.----1,000-100.00%-Sep 30, 2023

The largest ABVC BioPharma shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of ABVC BioPharma (ABVC), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----129-100.00%-Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.----1,000-100.00%-Sep 30, 2023
BLACKROCK INC.----5,814-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----18,421-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----22,101-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----139,282-100.00%-Sep 30, 2023

As of Sep 30 2023, ABVC BioPharma's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.13K stocks of ABVC, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GEODE CAPITAL MANAGEMENT, LLC----139,282-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----22,101-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----18,421-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Sep 30, 2023
BLACKROCK INC.----5,814-100.00%-Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.----1,000-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----129-100.00%-Sep 30, 2023

As of Sep 30 2023, ABVC BioPharma's biggest institutional seller is GEODE CAPITAL MANAGEMENT, LLC. The company sold -0.14M shares of ABVC, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GEODE CAPITAL MANAGEMENT, LLC----139,282-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----22,101-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----18,421-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----13,879-100.00%-Sep 30, 2023
BLACKROCK INC.----5,814-100.00%-Sep 30, 2023
SPOTLIGHT ASSET GROUP, INC.----1,000-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----129-100.00%-Sep 30, 2023

ABVC BioPharma's largest sold out institutional shareholder by shares sold is GEODE CAPITAL MANAGEMENT, LLC, sold -0.14M shares, valued at -, as of undefined.

ABVC BioPharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD INDEX FUNDS0.00%387,513--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%137,699--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%54,49436,173197.44%Dec 31, 2023
iSHARES TRUST0.00%11,876--Feb 29, 2024
EQ ADVISORS TRUST0.00%751--Dec 31, 2023

ABVC BioPharma's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 387.51K shares, compromising 0.00% of its total assets.

ABVC BioPharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 238-
31 Mar, 238-
31 Dec, 228-
30 Sep, 22860.00%
30 Jun, 22525.00%
31 Mar, 224-20.00%
31 Dec, 215-37.50%
30 Sep, 218-

As of 30 Jun 23, 8 institutions are holding ABVC BioPharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 23588,139-9.13%
31 Mar, 23647,2129.12%
31 Dec, 22593,122-4.64%
30 Sep, 22621,973-60.20%
30 Jun, 221,562,841265.33%
31 Mar, 22427,791-6.81%
31 Dec, 21459,042117.73%
30 Sep, 21210,827-

ABVC BioPharma (ABVC) has 588.14K shares outstanding as of 30 Jun 23, down -9.13% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 231.78%46.44%
31 Mar, 231.96%55.77%
31 Dec, 221.87%51.38%
30 Sep, 221.91%7.66%
30 Jun, 224.99%240.34%
31 Mar, 221.44%42.93%
31 Dec, 211.83%297.88%
30 Sep, 210.78%-

As of 30 Jun 23, ABVC BioPharma is held by 1.78% institutional shareholders, representing a 46.44% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 233-40.00%
31 Mar, 235-
31 Dec, 225-16.67%
30 Sep, 226100.00%
30 Jun, 223200.00%
31 Mar, 221-75.00%
31 Dec, 214-50.00%
30 Sep, 218-

3 institutional shareholders have increased their position in ABVC stock as of 30 Jun 23 compared to 5 in the previous quarter (a -40.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 232100.00%
31 Mar, 231-50.00%
31 Dec, 222100.00%
30 Sep, 221-
30 Jun, 22--100.00%
31 Mar, 222-
31 Dec, 21--
30 Sep, 21--

2 institutional shareholders have reduced their position in ABVC stock as of 30 Jun 23 compared to 1 in the previous quarter (a 100.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 238-588,139-9.13%1.78%46.44%3-40.00%2100.00%
31 Mar, 238-647,2129.12%1.96%55.77%5-1-50.00%
31 Dec, 228-593,122-4.64%1.87%51.38%5-16.67%2100.00%
30 Sep, 22860.00%621,973-60.20%1.91%7.66%6100.00%1-
30 Jun, 22525.00%1,562,841265.33%4.99%240.34%3200.00%--100.00%
31 Mar, 224-20.00%427,791-6.81%1.44%42.93%1-75.00%2-
31 Dec, 215-37.50%459,042117.73%1.83%297.88%4-50.00%--
30 Sep, 218-210,827-0.78%-8---

ABVC BioPharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 31, 2022An Chihliangofficer Chief Financial OfficerSell---13,334
Dec 10, 2021Odaira Yoshinobudirector-Sell---163,702
Nov 05, 2021King Chi-Hsin Richardofficer Chief Scientific OfficerSell---869
Nov 05, 2021Chou Yen-Hsindirector-Sell---5,679
Nov 05, 2021Doong Howardofficer Chief Executive OfficerSell---18,404
Oct 26, 2021Jiang Tsang Mingdirector-Sell---6,067
Sep 08, 2015Lazar Shulamitdirector, 10 percent owner, officer President,Secretary,TreasurerSell---60,000,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 12, 2022Jiang Shulingdirector, 10 percent owner Buy---7,908,805
Mar 31, 2022An Chihliangofficer Chief Financial OfficerSell---13,334
Dec 10, 2021Sakamoto Norimidirector Buy----
Dec 10, 2021Odaira Yoshinobudirector-Sell---163,702
Nov 15, 2021Jiang Tsung Shanndirector, officer CSO and DirectorBuy---12,103,971
Nov 15, 2021Miao Shin-Yudirector-Buy---67,378
Nov 15, 2021Tseng Shih-Chendirector Buy----
Nov 15, 2021Jiang Eugenedirector, officer Chairman of the Board & CBOBuy---732,716
Nov 15, 2021Jiang Chang-Jendirector-Buy---5,949
Nov 05, 2021King Chi-Hsin Richardofficer Chief Scientific OfficerSell---869
Nov 05, 2021Chou Yen-Hsindirector-Sell---5,679
Nov 05, 2021Doong Howardofficer Chief Executive OfficerSell---18,404
Oct 26, 2021Jiang Tsang Mingdirector-Sell---6,067
Sep 08, 2015Lazar Shulamitdirector, 10 percent owner, officer President,Secretary,TreasurerSell---60,000,000
Jan 27, 2012Stolz Kevin Patrickofficer VP & ControllerA-AwardBuy6,250--6,250
May 25, 2011Krotine Frank Thomasofficer COOA-AwardBuy300,000$0.20$60.00K300,000
May 11, 2011Stolz Kevin Patrickofficer CFO & ControllerA-AwardBuy50,000$0.20$10.00K50,000
May 11, 2011IANNOTTI DANIEL Vofficer VP, General Counsel & SecretarA-AwardBuy300,000$0.20$60.00K300,000
May 11, 2011Crockett Robert Gofficer Chief Executive OfficerA-AwardBuy1,800,000$0.20$360.00K1,800,000
May 11, 2011Ramsey Sally Judithdirector, officer VP New Product DevelopmentA-AwardBuy2,100,000$0.20$420.00K2,100,000

The last insider sell of ABVC BioPharma's stock was made by An Chihliang on Mar 31 2022, selling - shares at - per share (valued at -).

ABVC BioPharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2022---
Q4 2021---
Q3 2021-6-
Q3 2015-1-
Q1 201211100.00%
Q3 2011-3-
Q2 201151500.00%
Q3 201011100.00%
Q2 20101--
Q1 20103--
Q4 20094--
Q3 200951050.00%
Q2 200972350.00%
Q1 2009172850.00%
Q4 200831300.00%
Q3 200851500.00%
Q2 20085--
Q1 2008-5-
Q3 20071520.00%
Q2 2007---

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ABVC BioPharma's insiders, as of Q2 2022.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2022---
Q4 2021---
Q3 2021---
Q3 2015---
Q1 2012---
Q3 2011---
Q2 2011---
Q3 2010---
Q2 20101--
Q1 20102--
Q4 20094--
Q3 20092--
Q2 20097--
Q1 2009162800.00%
Q4 2008---
Q3 200841400.00%
Q2 2008---
Q1 2008---
Q3 20071--
Q2 2007---

As of Q2 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of ABVC BioPharma's stocks.

ABVC BioPharma Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
VRAXVirax Biolabs Group Limited
QNRXQuoin Pharmaceuticals, Ltd.
ALRNAileron Therapeutics, Inc.
SABSSAB Biotherapeutics, Inc.
MGTADianthus Therapeutics, Inc.
INDPIndaptus Therapeutics, Inc.
ARDSAridis Pharmaceuticals, Inc.
NTRBNutriband Inc.
LGVNLongeveron Inc.
RNXTRenovoRx, Inc.
ELDNEledon Pharmaceuticals, Inc.
KTTAPasithea Therapeutics Corp.
APTXAptinyx Inc.
BTTXBetter Therapeutics, Inc.
MNPRMonopar Therapeutics Inc.
ADTXAditxt, Inc.
EVLOEvelo Biosciences, Inc.
AKTXAkari Therapeutics, Plc
FBRXForte Biosciences, Inc.
ACSTAcasti Pharma Inc.

ABVC Ownership FAQ


ABVC BioPharma is owned by institutional shareholders (1.78%), insiders (26.25%), and public (71.97%). The largest institutional shareholder of ABVC BioPharma is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

ABVC BioPharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, and BLACKROCK INC.. The top five shareholders own together 0% of the company's share outstanding.

As of Jun 2023, there are 8 institutional shareholders of ABVC BioPharma.

WELLS FARGO & COMPANY/MN owns 0 shares of ABVC BioPharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

As of Sep 2023, NORTHERN TRUST CORP holds 0 shares of ABVC BioPharma (ABVC), compromising 0% of the company, valued at $0.

TWO SIGMA INVESTMENTS, LP is the third largest holder of ABVC BioPharma. The company owns 0 of the company's shares outstanding (worth $0).